Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 6 results

Author Title [ Type

] Year

Filters: Author is Devine, Steven M [Clear All Filters]

Journal Article

Brunstein, Claudio G, Ephraim J Fuchs, Shelly L Carter, Chatchada Karanes, Luciano J Costa, Juan Wu, Steven M Devine, et al.. 2011. “Alternative Donor Transplantation After Reduced Intensity Conditioning: Results Of Parallel Phase 2 Trials Using Partially Hla-Mismatched Related Bone Marrow Or Unrelated Double Umbilical Cord Blood Grafts.”. Blood 118 (2). Blood: 282-8. doi:10.1182/blood-2011-03-344853.

Keever-Taylor, Carolyn A, Steven M Devine, Robert J Soiffer, Adam Mendizabal, Shelly Carter, Marcelo C Pasquini, Parameswaran N Hari, et al.. 2012. “Characteristics Of Clinimacs® System Cd34-Enriched T Cell-Depleted Grafts In A Multicenter Trial For Acute Myeloid Leukemia-Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn) Protocol 0303.”. Biol Blood Marrow Transplant 18 (5). Biol Blood Marrow Transplant: 690-7. doi:10.1016/j.bbmt.2011.08.017.

Waller, Edmund K, Brent R Logan, Wayne AC Harris, Steven M Devine, David L Porter, Shin Mineishi, John M McCarty, et al.. 2014. “Improved Survival After Transplantation Of More Donor Plasmacytoid Dendritic Or Naïve T Cells From Unrelated-Donor Marrow Grafts: Results From Bmtctn 0201.”. J Clin Oncol 32 (22). J Clin Oncol: 2365-72. doi:10.1200/JCO.2013.54.4577.

Scott, Bart L, Marcelo C Pasquini, Brent R Logan, Juan Wu, Steven M Devine, David L Porter, Richard T Maziarz, et al.. 2017. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation For Acute Myeloid Leukemia And Myelodysplastic Syndromes.”. J Clin Oncol 35 (11). J Clin Oncol: 1154-1161. doi:10.1200/JCO.2016.70.7091.

C Howard, Alan, Marcelo A Fernandez-Vina, Frederick R Appelbaum, Dennis L Confer, Steven M Devine, Mary M Horowitz, Adam Mendizabal, Ginna G Laport, Marcelo C Pasquini, and Stephen R Spellman. 2015. “Recommendations For Donor Human Leukocyte Antigen Assessment And Matching For Allogeneic Stem Cell Transplantation: Consensus Opinion Of The Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn).”. Biol Blood Marrow Transplant 21 (1). Biol Blood Marrow Transplant: 4-7. doi:10.1016/j.bbmt.2014.09.017.

Laport, Ginna G, Juan Wu, Brent Logan, Veronika Bachanova, Chitra Hosing, Timothy Fenske, Walter Longo, et al.. 2016. “Reduced-Intensity Conditioning With Fludarabine, Cyclophosphamide, And High-Dose Rituximab For Allogeneic Hematopoietic Cell Transplantation For Follicular Lymphoma: A Phase Two Multicenter Trial From The Blood And Marrow Transplant Clinical Trials Networ”. Biol Blood Marrow Transplant 22 (8). Biol Blood Marrow Transplant: 1440-1448. doi:10.1016/j.bbmt.2016.04.014.